Huang, Shiu-Wen <br/><br/>
DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.  [electronic resource] 

 -  Oncotarget  Sep 2016 
 - 63124-63137 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.11152  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthraquinones--pharmacology<br/>Cell Movement<br/>Cell Proliferation<br/>Cell Survival<br/>Colorectal Neoplasms--blood supply<br/>Endothelial Cells--metabolism<br/>HCT116 Cells<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Mice, SCID<br/>Neoplasm Invasiveness<br/>Neoplasm Metastasis<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic--drug therapy<br/>Neuropilin-1--metabolism<br/>RNA, Small Interfering--metabolism<br/>Signal Transduction<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Vascular Endothelial Growth Factor Receptor-1--metabolism<br/>Vascular Endothelial Growth Factor Receptor-2--metabolism